PPM1A and prostate cancer: Intracardiac delivery of PPM1A-expressing human prostate cancer cells into nude mice resulted in a reduced incidence of metastases relative to non-engineered tumor cells; the tumor apoptotic rate was also significantly higher compared to tumors that developed in animals injected with empty vector-transduced prostate cells [53].